U.S. Medical Equipment Stock News

With inflation still running above the Fed’s 2% target and rate expectations shifting with every new comment from policymakers, many investors are rethinking how to position their portfolios. Defensive sector stocks can sometimes offer a steadier ride when interest rates and bond yields are in focus, because these companies sell essential goods and services that people tend to keep buying. This article looks at three U.S. defensive stocks that are closely exposed to the latest Federal Reserve...

Why Sensient Technologies Stock Is Back In Focus After Q2 Earnings Sensient Technologies (SXT) is on investors radar after reporting second quarter 2026 results alongside updated full year guidance and a fresh confirmation of its regular cash dividend. The company reported second quarter sales of US$462.08 million and net income of US$51.36 million, compared with US$414.23 million and US$37.59 million a year earlier. Diluted EPS from continuing operations was US$1.20 versus US$0.88. For the...

Q2 2026 results highlight ongoing losses and cash burn Disc Medicine (IRON) released second quarter and first half 2026 results on July 30, 2026, giving investors a fresh look at the company’s cash burn and earnings profile. For the second quarter, Disc Medicine reported a net loss of US$59.53 million compared with US$55.25 million a year earlier. Basic loss per share from continuing operations was US$1.54 compared with US$1.58 a year ago, which points to a slightly smaller per share loss...

Newell Brands (NWL) has just paired stronger second quarter earnings with a higher full year sales growth outlook and a new US$800 million asset based revolving credit facility, drawing fresh attention to the stock. See our latest analysis for Newell Brands. The latest earnings beat, higher sales outlook and new US$800 million credit facility appear to have shifted sentiment toward Newell Brands, with a 1-day share price return of 8.95% and a year-to-date share price return of 50.54%...

Houlihan Lokey (HLI) has been recognized as the leading M&A adviser by deal volume in North America for the first half of 2026, highlighting its role across a wide range of client transactions. See our latest analysis for Houlihan Lokey. Despite Houlihan Lokey’s leading M&A role, the stock has faced pressure, with the share price down 10.51% over the past week and 28.84% year to date. However, the 5-year total shareholder return of 58.27% reflects a stronger longer-term picture. After recent...

Madrigal Pharmaceuticals (MDGL) drew fresh attention on July 30, 2026, after reporting second quarter and six month results that showed wider net losses compared with the same periods a year earlier. See our latest analysis for Madrigal Pharmaceuticals. The latest results have coincided with pressure on Madrigal Pharmaceuticals' share price, which closed at $467.32 after falling 5.23% on the day and 14.18% over the past week. However, the 1 year total shareholder return of 54.65% points to...

Zebra Technologies Corporation recently reported quarterly results that exceeded analysts’ revenue and earnings expectations and raised guidance, following a 14.3% year-on-year revenue increase in the prior period. With the market now expecting revenue to grow 15.9% year on year this quarter, investor attention has intensified around whether Zebra can sustain its recent operational momentum. Next, we’ll examine how these stronger-than-expected results and upbeat revenue expectations might...

In the past quarter, ArcBest Corporation reported second-quarter 2026 sales of US$1,184.53 million, up from US$1,022.26 million a year earlier, but shifted from a net income of US$25.81 million to a net loss of US$13.82 million, while continuing share repurchases and affirming a US$0.12 quarterly dividend. Despite the headline GAAP loss, ArcBest’s improved asset-based operating ratio, non-GAAP profit beat, restructuring efforts, and launch of its ArcBestView digital logistics platform...

Biglari Holdings stock performance snapshot Biglari Holdings (BH.A) has drawn investor attention after recent share price moves, with the stock last closing at US$1,984.54. Returns show mixed short term performance, with a decline over the past month but gains over the past 3 months. See our latest analysis for Biglari Holdings. For context, Biglari Holdings has seen its share price pull back over the past month, even after a strong 3 month share price return of 28.42% and a 1 year total...

GE HealthCare Technologies recently reported its second-quarter 2026 results, showing higher revenue of US$5,295 million and net income of US$561 million year over year, while also completing a US$500 million share repurchase program, announcing a review of its challenged Patient Care Solutions unit, and managing a planned CFO transition. A key development is the launch of the Invenia ABUS Prime and ABUS StreamVue breast imaging systems, both cleared in the US and Europe, which broadens GE...

PTC Therapeutics reported second-quarter 2026 revenue of US$360.52 million and net income of US$83.5 million, and raised its full-year 2026 revenue outlook to between US$1.18 billion and US$1.28 billion, while also appointing long-serving human resources executive Hege Sollie-Zetlmayer to its board. An interesting angle is that the company’s strong quarterly profit contrasts with lower year-to-date revenue versus the prior year, raising questions about how its earnings quality and business...

Bread Financial Holdings, Inc. reported second-quarter 2026 results with net interest income of US$1,039 million and net income of US$146 million, while also completing a buyback of 7,343,098 shares for US$551.36 million and declaring a quarterly dividend of US$0.23 per share payable on September 15, 2026. The combination of higher earnings per share, a large completed repurchase that reduced the share count, and continued cash returns through dividends underscores management’s ongoing focus...

The latest round of Section 301 and Section 338 tariffs is prompting investors to reconsider how exposed portfolios are to complex global supply chains. Higher duties, extra compliance checks and uncertain trade rules can all squeeze margins or re-route production closer to home. That is where a curated US manufacturing and onshoring screener can help focus attention. It filters for larger, financially healthy companies with operations rooted in North America. In this article, you will see...

Sphere Entertainment Co. has reported past second-quarter 2026 results showing sales of US$313.64 million versus US$282.68 million a year earlier, alongside a shift from net income of US$151.82 million to a net loss of US$38.79 million. Despite reporting a loss, the company highlighted growing Sphere-driven revenue, venue expansion plans in Abu Dhabi and National Harbor, and a broader content slate including future Wizard of Oz and Rocky Horror Picture Show experiences. We will now examine...

TechnipFMC (FTI) is back in focus after reporting higher second quarter and first half 2026 revenue and net income compared with last year, while also reaffirming full year revenue guidance for its Subsea and Surface Technologies segments. See our latest analysis for TechnipFMC. TechnipFMC’s results and reaffirmed guidance come after a strong run, with the share price delivering a 51.47% year to date share price return and a very large 5 year total shareholder return. This is despite the 7...

In late July 2026, Hayward Holdings reported second-quarter 2026 results showing higher sales and net income year over year, reaffirmed its full-year 2026 outlook for approximately US$200 million in free cash flow, and highlighted low leverage, ample liquidity, and plans to pursue acquisitions alongside returning capital to shareholders. The combination of revenue outperformance, stable guidance, and an explicit intention to use strong cash generation to fund both organic investment and...

TriMas Corporation’s recent second-quarter and six-month 2026 results showed slightly higher sales of US$174.58 million and US$342.86 million respectively, alongside lower quarterly net income of US$13.37 million but a very large six‑month net income of US$814.2 million, while continuing its share repurchase program and affirming a US$0.0400 quarterly dividend. Beneath the headline numbers, the combination of improved profitability from continuing operations, a long-running buyback that has...

Sonic Automotive, Inc. reported past second-quarter 2026 results with revenue of US$3,934.0 million and net income of US$57.4 million, completing another US$6.82 million share buyback tranche and affirming a US$0.41 per-share dividend. The swing from a prior-year quarterly net loss to profit, alongside long-running buybacks totaling about US$1.29 billion, highlights management’s ongoing emphasis on shareholder returns and operational improvement. We’ll now examine how this return to...

Excelerate Energy (EE) is back in focus after its board approved a quarterly cash dividend of $0.09 per Class A share for the June 2026 quarter, representing a 13% increase from the prior payout. See our latest analysis for Excelerate Energy. Excelerate Energy’s recent dividend decision comes after a strong run in the stock, with a 90-day share price return of about 13.9% and a year to date share price return of 38.6%. The 1 year total shareholder return sits above 55%, signaling firm...

Jackson Financial (JXN) is entering a planned leadership transition that will place longtime finance executive Don W. Cummings in the Chief Executive Officer role and elevate Brian M. Walta to Chief Financial Officer. See our latest analysis for Jackson Financial. Jackson Financial’s leadership reshuffle arrives during a period of strong stock momentum, with a 30 day share price return of 16.98%, year to date share price return of 13.79%, and a 1 year total shareholder return of 50.40%,...

Callaway Golf Company recently reported its Q2 results after market hours, following a prior quarter in which it exceeded analysts’ revenue expectations and issued guidance that was stronger than anticipated. This time around, investors are focused on whether Callaway can deliver on expectations for year-on-year revenue to hold steady after last year’s decline, which could signal stabilizing demand across its golf entertainment and equipment businesses. Now we’ll examine how improving...

Iovance Biotherapeutics recently drew heightened attention as it prepared to report its second quarter 2026 results and corporate updates, including early commentary on the commercial rollout of its FDA-approved T cell therapy for solid tumors, Amtagvi. This focus on Amtagvi’s initial uptake and the company’s funding and execution risks has sharpened the debate over how fully Iovance’s long-term potential is reflected in its current valuation. We’ll now examine how the upcoming Amtagvi...

Teleflex Incorporated recently received U.S. FDA Biologics License Application approval for EZPLAZ Freeze Dried Plasma, the first FDA-licensed freeze dried plasma for adult transfusions when conventional plasma products are unavailable. This approval gives Teleflex its first biologics license for a blood component and introduces a patented flexible bag format that addresses battlefield and prehospital trauma care logistics. We’ll now examine how this first-of-its-kind FDA-approved freeze...

In July 2026, Paragon Advanced Labs announced a memorandum of understanding with McEwen Inc. to develop advanced laboratory services, including PhotonAssay, for the Gold Bar Mine Complex in Nevada, with potential future facilities at the Fox Complex in Ontario and El Gallo Mine in Mexico. An interesting aspect of this agreement is that McEwen will fund land and building construction while receiving a royalty on Paragon’s third-party lab revenues instead of rent, potentially creating a new...